SunBio,Inc. (KOSDAQ:067370)

SunBio,Inc. Statistics

Total Valuation

SunBio,Inc. has a market cap or net worth of KRW 78.07 billion.

Market Cap	78.07B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SunBio,Inc. has 12.31 million shares outstanding.

Current Share Class	12.31M
Shares Outstanding	12.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	31.81%
Owned by Institutions (%)	n/a
Float	8.35M

Valuation Ratios

The trailing PE ratio is 25.43.

PE Ratio	25.43
Forward PE	n/a
PS Ratio	35.96
PB Ratio	17.18
P/TBV Ratio	17.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.81

Current Ratio	10.81
Quick Ratio	10.59
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	15.38

Financial Efficiency

Return on equity (ROE) is 35.40% and return on invested capital (ROIC) is 4.92%.

Return on Equity (ROE)	35.40%
Return on Assets (ROA)	4.64%
Return on Invested Capital (ROIC)	4.92%
Return on Capital Employed (ROCE)	7.69%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.46
Inventory Turnover	8.98

Taxes

In the past 12 months, SunBio,Inc. has paid 109.82 million in taxes.

Income Tax	109.82M
Effective Tax Rate	7.30%

Stock Price Statistics

The stock price has increased by +0.95% in the last 52 weeks. The beta is 0.65, so SunBio,Inc.'s price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+0.95%
50-Day Moving Average	6,089.00
200-Day Moving Average	6,678.60
Relative Strength Index (RSI)	58.34
Average Volume (20 Days)	48,822

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SunBio,Inc. had revenue of KRW 2.17 billion and earned 1.39 billion in profits. Earnings per share was 249.33.

Revenue	2.17B
Gross Profit	1.23B
Operating Income	349.26M
Pretax Income	1.50B
Net Income	1.39B
EBITDA	403.98M
EBIT	349.26M
Earnings Per Share (EPS)	249.33

Balance Sheet

The company has 3.48 billion in cash and n/a in debt, giving a net cash position of 3.48 billion or 282.37 per share.

Cash & Cash Equivalents	3.48B
Total Debt	n/a
Net Cash	3.48B
Net Cash Per Share	282.37
Equity (Book Value)	4.54B
Book Value Per Share	812.94
Working Capital	3.76B

Cash Flow

In the last 12 months, operating cash flow was -823.92 million and capital expenditures -44.14 million, giving a free cash flow of -868.06 million.

Operating Cash Flow	-823.92M
Capital Expenditures	-44.14M
Free Cash Flow	-868.06M
FCF Per Share	-70.50

Margins

Gross margin is 56.69%, with operating and profit margins of 16.09% and 64.22%.

Gross Margin	56.69%
Operating Margin	16.09%
Pretax Margin	69.28%
Profit Margin	64.22%
EBITDA Margin	18.61%
EBIT Margin	16.09%
FCF Margin	n/a

Dividends & Yields

SunBio,Inc. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	13.36%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.79%
FCF Yield	-1.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 7, 2021. It was a forward split with a ratio of 1.5.

Last Split Date	Jan 7, 2021
Split Type	Forward
Split Ratio	1.5

Scores

SunBio,Inc. has an Altman Z-Score of 2.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.31
Piotroski F-Score	2